- Menopause
There is a menopause symptom that affects more women than hot flashes, and far fewer women ever bring it up with a clinician.
It shows up sometimes as vaginal dryness, discomfort, or pain during intercourse. As a burning or irritated feeling that doesn’t have an obvious cause. Sometimes as urinary urgency, or a UTI that keeps coming back no matter how much water gets consumed or how many bathroom trips get scheduled after intimacy.
These symptoms have a name: genitourinary syndrome of menopause, or GSM. It is not a vague catch-all or a normal price of aging to be quietly endured. It is a specific, well-understood, and highly treatable set of tissue changes with a clear physiological cause, and most women affected by it have never been told what is actually happening in their bodies, let alone what can be done about it.
This article walks through what GSM is, why it happens, how common it actually is, and what the evidence supports for treatment, so that a conversation with a clinician can start from a place of understanding rather than guesswork.
The vulva, vagina, and lower urinary tract are among the most estrogen-sensitive tissues in the body. During the reproductive years, estrogen keeps this tissue thick, elastic, and well-lubricated. It supports a healthy, protective vaginal microbiome and maintains the acidic vaginal environment that helps guard against infection. It also supports the tone and function of the urethra and bladder.
After menopause, circulating estrogen drops substantially, and without that hormonal support, these tissues gradually change:
These changes are grouped under one term, GSM, because they are not separate, unrelated problems. They are one hormonal shift showing up across a set of related tissues that were all calibrated to the presence of estrogen. A woman experiencing both vaginal dryness and recurring UTIs is not dealing with two unlucky coincidences. She is likely dealing with one underlying cause.
Estimates suggest that somewhere between 50 and 80 percent of post-menopausal women experience GSM symptoms to some degree. That makes it one of the most common menopause-related conditions, and also one of the most under-discussed.
There’s an important difference between GSM and hot flashes that’s worth naming directly: vasomotor symptoms like hot flashes tend to ease for many women over time. GSM typically does not follow that pattern. Left unaddressed, it tends to persist, and in many cases it gradually progresses. That makes it worth raising proactively rather than filing away as something to just get used to.
Multiple factors keep GSM under the radar. Embarrassment plays a role, since these symptoms touch on sex and bodily function in ways that can feel harder to discuss than a hot flash. So does the quiet assumption, sometimes reinforced by a rushed appointment, that vaginal dryness and urinary changes are just an inevitable feature of aging that nothing can really be done about.
Neither of those things is true. GSM is one of the most treatable menopause-related conditions that exists, and the range of options is broader than most women realize.
Treatment approaches range from accessible, non-hormonal options to targeted medical therapies, and the right fit depends on symptom severity, personal preference, and individual health history. This is general education, not a substitute for individualized clinical guidance.
Vaginal moisturizers, used regularly rather than only around sexual activity, help maintain tissue hydration over time. Their effect builds cumulatively with consistent use rather than working instantly.
Lubricants, used at the time of intimacy, reduce friction and discomfort in the moment. They address an immediate symptom but not the underlying tissue change, which is why many women use moisturizers and lubricants together for different purposes.
Pelvic floor physical therapy can help with the muscle tone, coordination, and connective tissue changes that often accompany GSM and affect urinary comfort and function.
Local vaginal estrogen can be delivered as a cream, tablet, suppository, or ring, and acts directly on vaginal and urethral tissue with minimal absorption into the rest of the body. Since it works at the site of application rather than systemically, it carries a different risk profile than oral or transdermal hormone therapy, but it is always best to discuss with your clinician who knows your health history.
This distinction matters enormously in practice. Major menopause societies have stated that low-dose local vaginal estrogen can be used safely by most women, including many women who are not candidates for systemic hormone therapy, such as some breast cancer survivors. A woman who has previously been told she cannot use estrogen owes it to herself to ask a specific follow-up question: does that guidance refer to systemic estrogen, local vaginal estrogen, or both? The answer may open up an option she was told didn’t exist for her.
For women who prefer a non-hormonal prescription route, ospemifene is an oral medication that acts on vaginal tissue. DHEA (prasterone) vaginal suppositories are another option with good evidence specifically for pain with intercourse. For women who are also managing hot flashes or other symptoms that call for systemic hormone therapy, that broader treatment will typically address GSM as part of the picture, though local therapy is often preferred when GSM is the primary concern.
Several GSM symptoms overlap with other conditions. Recurrent UTIs can have other contributing causes. Urinary urgency has more than one possible source. Vulvar pain has a differential diagnosis of its own. Getting an accurate picture matters for choosing the right treatment, and some health histories, like certain hormone-sensitive cancers, change the risk-benefit calculation for hormonal options in ways that require individual assessment.
The most useful step a woman can take is naming these symptoms explicitly and specifically at a clinical appointment, rather than mentioning them in passing or leaving them out entirely. “I’ve noticed vaginal dryness and pain with intercourse since menopause, and I’d like to understand my treatment options” opens a very different conversation than staying silent and assuming nothing can be done.
GSM is real, common, explainable, and treatable. It is not an inevitable cost of aging, or something a woman should have to just live with in silence. Understanding what’s happening in the body is the first step. The next is bringing it, clearly and specifically, to a clinician who can help find the right path forward.
Understanding one symptom is helpful. Understanding the transition changes the whole picture.
Clarity’s Menopause Learning Path teaches the physiology behind changing cycles, sleep, mood, cognition, temperature regulation, metabolism, and more.
EXPLORE MENOPAUSE →
This article is educational and is not a substitute for individualized medical advice. Speak with a clinician about your specific symptoms and health history before starting any treatment.
Dr. April Lind, Founder of MyClarity
As a physician in women’s health, I have spent years caring for women across life stages – adolescence, pregnancy, postpartum, infertility and into midlife. I created MyClarity because women deserve to understand what is happening in their bodies before they are told what to do about it.
Join my mailing list and receive new posts directly to your inbox.
